interferon-inducible neutrophil-driven blood transcriptional signature human tuberculosis 
tuberculosis tb caused infection mycobacterium tuberculosis major cause morbidity mortality worldwide efforts control hampered difficulties diagnosis prevention treatment people infected m tuberculosis remain asymptomatic termed latent tb % lifetime risk developing active tb disease current tests however identify individuals will develop disease immune response m tuberculosis complex incompletely characterized hindering development new diagnostics therapies vaccines identify whole-blood transcript signature active tb intermediate high-burden settings correlating radiological extent disease reverting healthy controls treatment subset patients latent tb signatures similar patients active tb also identify specific transcript signature discriminates active tb inflammatory infectious diseases modular pathway analysis revealed tb signature dominated neutrophil-driven interferon ifn-inducible gene profile consisting ifn-gamma type ifn-alpha beta signalling comparison transcriptional signatures purified cells flow cytometric analysis suggest tb signature reflects changes cellular composition altered gene expression although ifn-inducible signature also observed whole blood patients systemic lupus erythematosus sle complete modular signature differed tb increased abundance plasma cell transcripts studies demonstrate hitherto underappreciated role type ifn-alpha beta signalling pathogenesis tb implications vaccine therapeutic development study also provides broad range transcriptional biomarkers potential diagnostic prognostic tools combat tb epidemic 
